Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease

Annals of Oncology

Volumn 19, Issue 7, 2008, Pages 1299-1303

  Prasad, K N ^a   Saxena, A ^a   Ghoshal, U C ^a   Bhagat, M R ^b   Krishnani, N ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b Central Command   (India)

Author keywords

Gastric adenocarcinoma; Helicobacter pylori infection; Peptic ulcer disease; PPAR polymorphism

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; UREASE;

ADULT; ARTICLE; BACTERIUM CULTURE; CANCER RISK; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ADENOCARCINOMA;

EID: 46249125608     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn055     Document Type: Article

References (24)

1. Ohata H, Kitauchi S. Yoshimura N et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-143.
2. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 177-241.
3. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
4. El-Omar EM, Chow WH, Rabkin CS. Gastric cancer and H. pylori: Host genetics open the way. Gastroenterology 2001; 121: 1002-1004.
5. Ghoshal UC, Tiwari S, Pandey R et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasm and controls: The Indian enigma. Am J Gastroenterol 2005; 100: S64.
6. Michalik L, Desvergne B, Wahli W. Peroxisome-proliferator-activated receptors and cancers: Complex stories. Nat Rev Cancer 2004; 4: 61-70.
7. Greene ME, Blumberg B, McBride OW et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping. Gene Expr 1995; 4: 281-299.
8. Elbrecht A, Chen Y, Cullinan CA et al. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 1996; 224: 431-437.
9. Farmer S. Transcriptional control of adipogenesis: Interplay between C/ EBPs and PPARγ in regulating adipocyte gene expression. In Medeiros-Neto G (ed): Progress in Obesity Research. Paris: John Libbey Eurotext, 003; 15-18.
10. Yen CJ, Beamer BA, Negri C et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gammat gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamm 2 missense mutation. Biochem Biophys Res Commun 1997; 241: 270-274.
11. Landi S, Moreno V, Gioia-Patricola L et al. Association of common polymorphisms in inflammatory genes interleukin (IL) 6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 2003; 63: 3560-3566.
12. Murtaugh MA, Ma KN, Caan BJ et al. Interactions of peroxisome proliferator-activated receptor [gamma) and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1224-1229.
13. Paltoo D, Woodson K, Taylor P et al. Pro12Ala polymorphis in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study. Cancer Lett 2003; 191: 67-74.
14. Paynter RA, Hankinson SE, Colditz GA et al. No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility. Pharmacogenetics 2004; 14: 851-856.
15. Gong Z, Xie D, Deng Z et al. The PPAR (gamma) Pro12Ala polymorphism and risk for incident sporadic oolorectal adenomas. Carcinogenesis 2005; 26: 579-585.
16. Tahara T, Arisawa T, Shibata T et al. Influence of peroxisome proliferator-activated receptor (PPAR) gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese. Dig Dis Sci 2007; In press.
17. Liao SY, Zeng ZR, Leung WK et al. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese. Aliment Pharmacol Ther 2006; 23: 289-294.
18. Singh M, Prasad KN, Yachha SK, Krishnani N. Genotypes of Helicobacter pylori in children with upper abdominal pain. J Gastroenterol Hepatol 2003; 18: 1018-1023.
19. Konturek PC, Kania J, Konturek JW et al. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPARγ and impaired apoptosis in gastric carcinogenesis. Med Sci Monit 2003; 9: SR65-SR78.
20. Loung WK, Bai AH, Chan VY et al. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene axpression profiles of gastric cancer cells. Gut 2004; 53: 331-338.
21. Lu J, Imamura K, Nomura S et al. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res 2005; 65: 4769-4774.
22. Meirhaeghe A, Amouyel P. Impact of genetic variation of PPARgamma in humans. Mol Genet Metab 2004; 83: 93-102.
23. Stumvoil M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002; 51: 2341-2347.
24. Gupta RA, Polk DB, Krishna U et al. Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem 2001; 276: 31059-31066.